327 related articles for article (PubMed ID: 19836804)
1. Operator is an independent predictor of detecting prostate cancer at transrectal ultrasound guided prostate biopsy.
Lawrentschuk N; Toi A; Lockwood GA; Evans A; Finelli A; O'Malley M; Margolis M; Ghai S; Fleshner NE
J Urol; 2009 Dec; 182(6):2659-63. PubMed ID: 19836804
[TBL] [Abstract][Full Text] [Related]
2. Can a trained non-physician provider perform transrectal ultrasound-guided prostatic biopsies as effectively as an experienced urologist?
Hori S; Fuge O; Trabucchi K; Donaldson P; McLoughlin J
BJU Int; 2013 May; 111(5):739-44. PubMed ID: 22726849
[TBL] [Abstract][Full Text] [Related]
3. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
Djavan B; Waldert M; Zlotta A; Dobronski P; Seitz C; Remzi M; Borkowski A; Schulman C; Marberger M
J Urol; 2001 Sep; 166(3):856-60. PubMed ID: 11490233
[TBL] [Abstract][Full Text] [Related]
4. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
[TBL] [Abstract][Full Text] [Related]
6. The continuing importance of transrectal ultrasound identification of prostatic lesions.
Toi A; Neill MG; Lockwood GA; Sweet JM; Tammsalu LA; Fleshner NE
J Urol; 2007 Feb; 177(2):516-20. PubMed ID: 17222623
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate Cancer.
Costa DN; Lotan Y; Rofsky NM; Roehrborn C; Liu A; Hornberger B; Xi Y; Francis F; Pedrosa I
J Urol; 2016 Jan; 195(1):80-7. PubMed ID: 26192254
[TBL] [Abstract][Full Text] [Related]
8. The eternal enigma in prostatic biopsy access route.
Fabiani A; Principi E; Filosa A; Servi L
Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate.
Fleshner NE; O'Sullivan M; Fair WR
J Urol; 1997 Aug; 158(2):505-8; discussion 508-9. PubMed ID: 9224334
[TBL] [Abstract][Full Text] [Related]
11. [Prospective study comparing ultrasonography guided trans-rectal biopsy and finger guided trans-perineal biopsy in the diagnosis of prostatic cancer].
Garcia G; Chevallier D; Amiel J; Toubol J; Michiels JF
Prog Urol; 2001 Feb; 11(1):40-3; discussion 43-4. PubMed ID: 11296644
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer.
Kawakami S; Yamamoto S; Numao N; Ishikawa Y; Kihara K; Fukui I
Int J Urol; 2007 Aug; 14(8):719-24. PubMed ID: 17681062
[TBL] [Abstract][Full Text] [Related]
13. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
[TBL] [Abstract][Full Text] [Related]
14. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-guided transrectal extended prostate biopsy: a prospective study.
Al-Ghazo MA; Ghalayini IF; Matalka II
Asian J Androl; 2005 Jun; 7(2):165-9. PubMed ID: 15897973
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
17. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
[TBL] [Abstract][Full Text] [Related]
18. [Influence of learning curve in the diagnosis of prostate cancer by ultrasound guided biopsy].
Escudero-Fontano E; Juan-Escudero J; Nuño de la Rosa-García I; Amorós-Torres A; Sobrón-Bustamante M; Durán-Rivera A; Ramos-Campos M; Marqués-Vidal E
Arch Esp Urol; 2015; 68(6):532-8. PubMed ID: 26179790
[TBL] [Abstract][Full Text] [Related]
19. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
[TBL] [Abstract][Full Text] [Related]
20. [Ultrasonography-guided transrectal prostatic biopsy: indications, methods, complications. Our experience].
Borsa R; Moiso A; Fontana G
Arch Ital Urol Androl; 2002 Dec; 74(4):290-1. PubMed ID: 12508754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
